25 January

Eur Heart J https://academic.oup.com/site_5375/

• 01:00
  Interplay between post-myocardial infarction ejection fraction and atrial fibrillation: implications for ischemic stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore Ministry of Health’s National Medical Research CouncilBackgroundThere are little data on the interplay between post-acute myocardial infarction (MI), left ventricular (...)
• 01:00
  Different cellular landscape of four types of non-diseased cardiac valves contributes to their differences in susceptibility of pathological remodeling and disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): National Natural Science Foundation of ChinaBackgroundExploring the mechanisms of valvular heart disease (VHD) at the cellular level may be useful to identify new therapeutic targets; however, the (...)
• 01:00
  Preliminary results of whole exome sequencing in a clinical hypertrophic cardiomyopathy cohort in India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHypertrophic cardiomyopathy (HCM), characterized by unexplained left ventricular hypertrophy and outcomes ranging from normal life expectancy to heart failure and sudden cardiac death, has a global prevalence of about 1 in (...)
• 01:00
  Characteristics and outcomes of aortic stenosis patients with and without stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Sia CH was supported by the National University of Singapore Yong Loo Lin School of Medicine’s Junior Academic Faculty SchemeBackgroundAortic stenosis (AS) is related to several (...)
• 01:00
  Cardiac valve surgery in Far North Queensland, Australia. A retrospective audit of rheumatic heart disease prevalence, patient demographics and surgical management Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRheumatic heart disease (RHD) is a preventable valve disease following acute rheumatic fever. It results in >300,000 deaths annually worldwide (1). While commonly encountered in the developing world, the prevalence in (...)
• 01:00
  Intravascular lithotripsy in calcified coronary lesions-A single tertiary care center experience from India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.AimsSevere coronary calcification is a serious impediment to optimal stent expansion and can lead to stent failure and adverse outcomes. We hereby present Indian experience with intravascular lithotripsy(IVL) for the treatment of (...)
• 01:00
  Comparison of transcatheter, minimally invasive and conventional surgical aortic valve replacement: a systematic review and network meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionThe landscape of aortic valve replacement (AVR) has evolved dramatically over the years, but long-term outcomes have yet to be comprehensively explored.PurposeTo compare long-term mortality among three AVR (...)
• 01:00
  Safety and efficacy of cerebral embolic protection devices in transcatheter aortic valve implantation: a meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundStroke during Transcatheter Aortic Valve implantation (TAVI) is not an uncommon complication with potential devastating consequences. With the extension of TAVI to the low-risk patient, stroke prevention takes on increasing (...)
• 01:00
  Prognostic value of longitudinal assessment of inflammatory and nutritional status in patients undergoing valvular heart surgery Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundNovel strategies to improve the long-term risk stratification of valvular surgery are urgently needed as a result of the increasing prevalence of valvular heart diseases globally.PurposeThis study aimed to evaluate the (...)
• 01:00
  Implementation evaluation of mhealth interventions in the secondary prevention of coronary artery disease: a supplementary review Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): La Trobe UniversityIntroductionmHealth technologies have evolved rapidly in recent years and are now widely implemented for the secondary prevention of coronary artery disease (CAD). While (...)
• 01:00
  Prospective evaluation of digital therapeutic intervention on blood pressure control in Indian patients with uncontrolled primary hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Terrals Technologies Private LimitedBackgroundDigital therapeutics (DTx) has emerged as a new approach in recent years making use of connected devices, smartphone software and (...)
• 01:00
  Evaluation of cardiovascular risk scores after implementation of digital therapeutic intervention in patients with uncontrolled primary hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Terrals Technologies Private LimitedBackgroundCardiovascular risk scores serve as a useful tool to reinforce the importance of lifestyle modifications and treatment compliance. (...)
• 01:00
  The global syndemic of metabolic diseases in the young adult population: a consortium from the Global Burden of Disease 2000-2019 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundA large proportion of premature deaths are related to metabolic diseases in the young adult population. We examined the global trends and mortality of metabolic diseases using estimates from the Global Burden of Diseases, (...)
• 01:00
  Heart failure (MYHF) registry: shedding light on lipid profiles and in-hospital outcome of heart failure patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis Corporation Sdn BhdBackgroundHeart failure is a debilitating disease associated with multiple comorbidities and poor prognosis. Dyslipidemia, is the top 5 most common comorbidities, (...)
• 01:00
  Pattern of life style in patients from one subset of rural Tamil Nadu-India, after coronary angioplasty Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLife after percutaneous coronary angioplasty (PTCA) has been sparsely studied unlike the plethora of studies after coronary bypass surgery (CABG). It is mandatory that the patient make life style changes and be drug (...)
• 01:00
  Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): The Japan Cardiovascular Research Foundation under a contract with Bayer YakuhinBackgroundThe AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery (...)
• 01:00
  Nationwide trends of gatekeeper to invasive coronary angiography in suspected coronary artery disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and ObjectivesReal-world trends in the utility and type of gatekeeping studies in invasive coronary angiography (ICA) requires further investigation.MethodsWe identified outpatients who underwent noninvasive cardiac tests (...)
• 01:00
  Abnormal left atrial strain is associated with eventual diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPatients with embolic stroke of undetermined source (ESUS) have no immediate attributable cause despite initial evaluation. Occult paroxysmal atrial fibrillation (pAF) diagnosed on prolonged electrocardiographic monitoring (...)
• 01:00
  Long-term results of zero-fluoroscopy catheter ablation in pregnant patients with arrhythmias: a 2-year follow-up study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundIncidences of rhythm disturbance in pregnant are commonly seen. Catheter ablation of arrhythmias has been shown to be effective and safe. Data on perinatal outcomes and results of zero-fluoroscopy catheter ablation in (...)
• 01:00
  The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and AimsAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia in post-cardiac surgery. It is associated with substantial morbidity and mortality, thus portending a significant burden to patients and the (...)
• 01:00
  Implementation of point-of-care INR testing to improve effectiveness of anticoagulation clinic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionOral Vitamin K antagonist (VKA) is still widely used for anticoagulation. Anticoagulation clinics are set up to monitor patients’ INR and adjust their VKA doses accordingly. Anticoagulation clinic in our centre introduced (...)
• 01:00
  Comparison of adhesive single-lead cardiac ECG patch device with Holter monitoring for detecting atrial fibrillation after an acute cerebral ischemic event: An interim analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health MalaysiaBackgroundStroke secondary to atrial fibrillation (AF) is common and often associated with higher risk of stroke recurrence. Detection of AF is (...)
• 01:00
  Influence of non-apical permanent pacing on left ventricular systolic impairment Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRight ventricular apical (RVA) pacing deleterious effects on left ventricular ejection fraction (LVEF) had been demonstrated. Non-apical pacing, such as right ventricular mid-septal (RVMS) and His Bundle pacing, appear as (...)
• 01:00
  Advantages of leadless pacemakers compared to conventional pacemakers Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLeadless pacemakers (L-PM) are a new safe alternative technology for pacing the right ventricle. However, not enough information is available on their potential benefits for quality of life (QoL) in patients with L-PM. The (...)
• 01:00
  Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionPatients with HFpEF usually have severe exercise intolerance which leads to poor quality of life. While SGLT2 inhibitors in HFrEF patients have been proven beneficial, with HFpEF it remains uncertain. This meta-analysis (...)
• 01:00
  Efficacy of sodium glucose cotransporter 2 inhibitors for heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundSGLT2 inhibition has been a breakthrough approach in the treatment for heart failure. A most recent trial of Dapagliflozin has shown its robust benefit in patients with HFpEF and HFmrEF. However, the positive outcomes of (...)
• 01:00
  SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundSodium glucose co-transporter 2 (SGLT2) inhibitors have been recommended in the practice guidelines for the treatment of patients with heart failure with reduced ejection fraction, however their effects among patients with (...)
• 01:00
  Clinical characteristics, management, and outcomes of acute heart failure patients in Central Asia Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiovascular disease (CVD) is the leading cause of death in Central Asia. In 2019, crude mortality rate in the region was 348.13 per 100,000 population. Heart failure (HF) is important CVD subtype owing to even worse (...)
• 01:00
  Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis Corporation Sdn BhdBackgroundIn real world settings, factors that may affect prognosis of HF patients include comorbidities, lack of guideline-directed medical therapies (GDMT) and (...)
• 01:00
  Estimation of brain natriuretic peptide values from N-terminal pro brain natriuretic peptide levels and other factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundsBoth brain natriuretic peptide (BNP) and N-terminal proBNP (NT-pro BNP) are established biomarkers that are necessary in the diagnosis and management of heart failure (HF). Recently with the introduction of angiotensin (...)
• 01:00
  Cardiac tamponade in a multiracial population- epidemiology, clinical characteristics and survival outcomes - a single centre experience Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiac tamponade is a medical emergency which requires prompt medical intervention via pericardiocentesis. Diverse etiologies has been attributed, with malignancy and Tuberculous effusions being the leading causes. The aim (...)
• 01:00
  Long term survival of antenatally diagnosed functionally single ventricle congenital heart disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAntenatal diagnosis of single ventricle congenital heart disease (CHD) allows prenatal counselling, better parental preparation and support as well as improved perinatal management. Expectant parents frequently ask about (...)
• 01:00
  Cardiovascular profile and electrocardiographic findings of hospitalized adult patients during the surge of delta and omicron variants of COVID-19 in a COVID-19 tertiary referral center Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCOVID-19 has been reported to cause cardiac injury. It can be detected by an electrocardiogram (ECG), which may show markers that may predict clinical outcome. Robust data on the ECG abnormalities among COVID-19 patients (...)
• 01:00
  Seven-day holter monitoring detects more significant arrhythmias than 24-hour and 3-day monitoring Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/Introduction24-hour Holter monitors have been used widely to assess patients with suspected and known arrhythmias. Recent studies have shown increased yield of arrhythmia detection with longer durations of Holter (...)
• 01:00
  Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectivesTo determine the association between levels of triglyceride (TG) and all-cause mortality and cardiovascular outcomes. To evaluate the concentration of TG associated with the lower range and lowest risk of adverse outcomes (...)
• 01:00
  Association between ACE I/D gene polymorphism and coronary artery lesion characteristics in patients with acute myocardial infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAcute myocardial infarction (AMI) remains a public health issue with high morbidity and mortality rates and significantly reduces patients' health-related quality of life. The identification of factors influencing coronary (...)
• 01:00
  The surprises in optical coherence tomography (OCT) findings in patients presenting with in-stent restenosis: the road less travelled Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMorphological features of neointimal tissue play a pivotal role in the pathophysiology of In-Stent Restenosis (ISR) after percutaneous coronary intervention, hence understanding these features and patterns is (...)
• 01:00
  A novel cardiac arrest severity score for the early prediction of hypoxic-ischemic brain injury and in-hospital death Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOut-of-hospital cardiac arrest (OHCA) outcomes are unsatisfactory despite postcardiac arrest care. Early prediction of prognoses might help stratify patients and provide tailored therapy.PurposeIn this study, we derived and (...)
• 01:00
  Novel serum biomarkers for predicting prognosis in post cardiac arrest patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectiveTo determine the clinical feasibility of novel serum biomarkers by comparing them with conventional serum biomarkers in out-of-hospital cardiac arrest (OHCA) patients treated with target temperature management (...)
• 01:00
  In-hospital outcomes of rotational atherectomy in relation to operator volumes: data from an asian national databank Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionStudies investigating the relationship between percutaneous coronary intervention operator volumes and patient adverse events largely, but not consistently, suggest an inverse association. A recent study of rotational (...)
• 01:00
  High thrombotic risk is associated with higher prevalence of suboptimal stent results in patients with high bleeding risk Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundShorter duration of dual antiplatelet therapy after drug-eluting stent implantation is required in patients with high bleeding risk (HBR) irrespective of the presence of concomitant high thrombotic risk (HTR). The (...)
• 01:00
  Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOccurrence of hyperkalemia has been a great limitation in the full implementation of a guideline-directed medical therapy especially in patients with heart failure. Recent developments have exhibited the positive role of (...)
• 01:00
  Machine learning accurately quantifies epicardial adipose tissue from non-contrast CT images in coronary artery disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Industry Alignment Fund – Pre-positioning ProgrammeBackgroundEpicardial adipose tissue (EAT) is the visceral fat deposit within the pericardium that surrounds the heart and the coronary arteries. EAT volume (...)
• 01:00
  Applying an interpretive machine learning algorithm to predict in-hospital mortality in elderly asian patients with acute coronary syndrome (ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Mosti TED1 grantBackgroundNo study has used interpretative Machine Learning (ML) algorithms to predict in-hospital mortality for the Asian elderly (65+). TIMI predicts (...)
• 01:00
  System delays and target points: analysis of STEMI response program a single center Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSTEMI carries the highest risk among the AMI and the mortality is influenced by many factors. Hospital delays are the most easily audited and should be analyzed and improved.MethodologyParticipants were adults aged > 19 (...)
• 01:00
  The diagnostic utility of cardiac imaging (echocardiogram and cardiac MRI) in COVID 19 patients and cardiac complications: retrospective cohort study in Saudi Arabia Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionCoronavirus disease (COVID-19) continues to cause considerable morbidity and mortality worldwide. The complication in patients with severe COVID-19 disease include arrhythmias, peri-myocarditis (PM), and heart (...)
• 01:00
  Electrocardiographic predictors of disease severity, mortality, and advanced ventilatory support among hospitalized covid-19 patients: a two year single center retrospective, cohort study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionFor detecting myocardial injury in severe and critical COVID-19, the electrocardiogram (ECG) is neither sensitive nor specific; but in a resource-poor environment, it remains relevant. Changes in the ECG can be a (...)
• 01:00
  The single-syringe versus the double-syringe techniques of adenosine administration for supraventricular tachycardia: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIntravenous double-syringe technique (DST) of adenosine administration consists of an intravenous bolus of adenosine via three-way stopcock followed by an immediate 10-20ml sodium chloride 0.9% flush and is the (...)
• 01:00
  Estimated glucose disposal rate, a novel biomarker for insulin sensitivity, predicts risk for incident heart failure in patients with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore National Medical Research CouncilSingapore Khoo Teck Puat Hospital STAR grantBackgroundAlthough a low insulin sensitivity (insulin resistance) has been considered as (...)
• 01:00
  Sex differences in the evaluation and outcomes of multi-ethnic asian patients undergoing stress echocardiography Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionStress echocardiography is an important test used in the evaluation of myocardial ischemia. Despite this, not much is known about sex differences between men and women undergoing stress echocardiography, with (...)
• 01:00
  Electrocardiographic findings and incidence of new-onset atrial arrhythmia among patients with severe leptospirosis who underwent veno-venous extracorporeal membrane oxygenation Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundLeptospirosis is a zoonotic disease caused by Leptospira species that remains endemic in the Philippines. In severe cases, patients present with multiple organ system failure such as acute renal failure and acute (...)
• 01:00
  Efficacy of cryoablation versus antiarrhythmic therapy for treatment of atrial fibrillation: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionAtrial fibrillation (AF) is a common arrhythmia that causes various complications if left untreated. Current primary care guidelines recommend administration of antiarrhythmic drugs (AAD) as the preferred treatment (...)
• 01:00
  Optimal international normalized ratio target in east asian populations with atrial fibrillation: systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough current guidelines recommend the use of direct oral anticoagulants in patients with non-valvular atrial fibrillation (NVAF), the use of vitamin K antagonists (VKA) is still very widespread, especially in low to (...)
• 01:00
  Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDuring the COVID-19 pandemic, systematic switching patients of eligible patients with atrial fibrillation from warfarin to direct oral anticoagulants (DOACs) was encouraged to simplify drug dosing and obviate the need for (...)
• 01:00
  Factors Associated with Coronary Artery Calcification and Cardiovascular Outcome Among Pre-Dialysis Chronic Kidney Disease Patients in Phramongkutklao hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiovascular disease is the leading cause of death in chronic kidney disease (CKD) patients. Calcified coronary artery is highly prevalent and more severe among these group. Coronary calcium score was used as a risk (...)
• 01:00
  Impact of novel risk factors of atherosclerosis on severity of coronary artery disease in young Indian patients suffering from Myocardial Infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAsian Indians are affected at least a decade earlier with cardiovascular diseases (CVD), in their most productive midlife years as compared to people of European ancestry. This is the first study from Indian sub-continent (...)
• 01:00
  Contemporary review of the management of left ventricular thrombus Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionLeft ventricular thrombus (LVT) is a known complication of acute myocardial infarction (AMI) and other cardiomyopathies. LVT increases the risk of stroke and systemic embolism, hence treatment with oral anticoagulation is (...)
• 01:00
  Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): A consortium of six companies in Korea (Daiichi Sankyo, Boston Scientific, Terumo, Biotronik, Qualitech Korea, and Dio).BackgroundPatients with coronary artery disease and impaired renal function (...)
• 01:00
  Natural history of functional mitral regurgitation: a systematic review and individual patient data meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Ching-Hui Sia was supported by the National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme.BackgroundFunctional mitral regurgitation (FMR) (...)
• 01:00
  Effects of medical therapy, transcatheter intervention, and surgery on outcomes of patients with functional mitral regurgitation: a systematic review and network meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): Ching-Hui Sia was supported by the National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship Scheme.BackgroundFunctional mitral regurgitation (FMR) is the (...)
• 01:00
  Predictors of mortality in Vietnamese patients with infective endocartis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundInfective endocarditis (IE) has been associated with an elevated mortality rate despite major advances in diagnostic and therapeutic methods for the past decades.Purposeto evaluate predictors of in-hospital all-cause (...)
• 01:00
  Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Sanming Project of Medicine in Shenzhen, China;HKU-SZH Fund for Shenzhen Key Medical DisciplineBackgroundProsthetic valve endocarditis (PVE) is a rare but serious complication following valvular (...)
• 01:00
  Comorbidity patterns in older patients with diabetes in primary care: a cross-sectional study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundDiabetes is a well-known risk factor for cardiovascular diseases and continues to be a global public health challenge. In Australia, prevalence rates of diabetes increase with age with almost 1 in 5 older people reported (...)
• 01:00
  Contrast induced nephropathy in older Vietnamese patients undergoing coronary angiography and intervention Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe prevalence of coronary heart disease increases with age and older people accounted for a large proportion of patients presenting with coronary heart disease. Advancement in percutaneous coronary intervention (PCI) has (...)
• 01:00
  Pre-diabetes is associated with increases cardiac event in cancer patients treated with anthracyclines Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): University of Hong Kong, Queen Mary HospitalObjectiveTo evaluate the association between pre-diabetes and cardiovascular events in patients treated with anthracyclines containing chemotherapy (...)
• 01:00
  Cardiovascular disease in older patients with end-stage renal disease and chronic dialysis in Vietnam Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPatients with chronic kidney disease, especially end-stage renal disease, exhibit a very high cardiovascular risk. In Vietnam, chronic kidney disease and cardiovascular disease (CVD) are very common in older people. (...)
• 01:00
  Intraventricular pressure gradient: a novel colour M-mode echocardiographic-derived imaging modality to assess and predict the alterations following acute myocardial infarction Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMyocardial infarction (MI), caused by partial or total interruption of myocardial blood supply, is among the leading causes of morbidity and death. It can go silent (undetected), or it can be a catastrophic occurrence with (...)
• 01:00
  Unraveling the invisible demon: a study of the oxidative stress markers, antioxidant activities and inflammatory markers in patients admitted with complete heart block Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionDespite the recent advancements in the management of Complete Heart Block (CHB), the aetiology of CHB is still idiopathic in most of the cases. Our study explores this hitherto untouched aspect of complete heart (...)
• 01:00
  Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe Amplatzer Amulet and Watchman devices are the two most frequently used devices for percutaneous LAA closure globally.AimTo evaluate the safety and clinical outcomes associated with these two devices in patients (...)
• 01:00
  Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundRight heart and renal dysfunction occurring due to volume fluid redistribution remain a front-line issue in the development of the syndrome of congestion in chronic heart failure (HF). Quantitative total blood volume (TBV) (...)
• 01:00
  HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundGlycemic control is an important clinical issue in the management of patients with heart failure (HF). Variability of Glycated hemoglobin A1c (HbA1c) has been proven to be a predictor of cardiovascular events. However, (...)
• 01:00
  Accuracy in precise DAPT score compared with CRUSADE score in Thai population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public hospital(s). Main funding source(s): Rajavithi hospitalIntroductionMyocardial infarction is one of the most common cardiovascular disease in the world including Thai population. The current treatment strategy is percutaneous (...)
• 01:00
  Predictors of angiographically normal coronary arteries Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCoronary angiography (CAG) has been recommended for patients with well-established risk factors. However, striking rates of coronary angiograms were turning out to be normal and very little is known regarding the (...)
• 01:00
  Investigating factors associated with the prevalence of IHD among uncontrolled diabetic patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Monash University MalaysiaBackgroundIschaemic Heart Disease (IHD) is the leading cause of death in Malaysia (1), and there is an increasing trend in mortality due to IHD from 15.2% in 2019 to 17.2% in 2020 (...)
• 01:00
  Increased level of plasma Cyclophilin A in early diabetic population suggesting it as a reliable pro inflammatory biomarker of coronary artery disease in diabetic patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Other. Main funding source(s): Institute of Cardiovascular disease, Madras Medical MissionBackgroundType 2 Diabetes (DM) is a pro-inflammatory state in the pathogenesis of Atherosclerosis with the presence of many active proteins, of (...)
• 01:00
  Differential expression of TLR4 in patients of coronary artery disease with and without traditional cardiovascular risk factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAtherosclerosis is inherently an inflammatory process, with a complex interplay of inflammatory markers. It is established that these inflammatory markers play an important role in patients of Coronary Artery Disease(CAD) (...)
• 01:00
  Higher risk of adverse cardiovascular outcomes in women with type 2 diabetes mellitus: an umbrella review of systematic reviews Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrevious studies have shown that females with type 2 diabetes mellitus (T2DM) may have an excess mortality risk compared to males. Furthermore, other studies have reported sex differences in managing cardiovascular risk (...)
• 01:00
  Perceptions, insights, and attitudes (P.I.A.) of selected filipino female physicians on cardiovascular risks and diseases Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIn 2012, coronary heart disease and stroke are the leading causes of death worldwide, accounting for more than 31% of deaths from all causes. In 2020, PH statistics showed that ischemic heart diseases were the leading (...)
• 01:00
  Cardiac rehabilitation results among patients who have undergone cardiac surgery after covid-19 infection Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCoronavirus disease 2019 (Covid-19) has become a global pandemic. Covid-19 increases morbidity in patients with underlying cardiovascular disease. The six-minute walk test (6MWT) is a simple test for assessing (...)
• 01:00
  The impact of diabetes mellitus on improvement of resting rate pressure product in patients with refractory angina undergone external counter pulsation Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe management of coronary artery disease (CAD) has developed significantly in the last few decades. One of the therapeutic modalities that could be considered to patients with refractory angina caused by CAD is external (...)
• 01:00
  Real-world comparison of intracoronary imaging and fractional flow reserve measurements on outcomes of semi-urgent and elective percutaneous coronary intervention in a multi-ethnic asian population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundIntracoronary imaging and fractional flow reserve measurements (FFR) are helpful in optimisation of percutaneous coronary intervention (PCI) for patients with stable coronary artery disease, but their comparative efficacy (...)
• 01:00
  A meta-analysis on the efficacy of influenza vaccine in reducing cardiovascular mortality and myocardial infarction in patients with cardiovascular disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionInfluenza infection has been linked to adverse cardiovascular events in coronary artery disease (CAD) patients. Despite the compelling link between influenza vaccine’s protective potential in observational studies, the (...)
• 01:00
  Correlation of Echoradiography Pulmonary to Left Atrial Ratio (ePLAR) with Right Heart Catheterization Parameters in Pulmonal Arterial Hypertension Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundUntil now, right heart catheterization is still the gold standard for pulmonary hypertension examination, but this examination is invasive, has a risk of action, and is limited. Echocardiography provides an alternative (...)
• 01:00
  The effect of ras human orthologue kinase inhibitor on the treatment of pulmonary hypertension: a systematic review Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPulmonary hypertension (PH) is a high mortality and an uncrackable disease up to date. The complex pathophysiology is one of the reasons for only a view treatment that can be given to patients with PH. Recent studies have (...)
• 01:00
  Efficacy of home-based versus centre-based cardiac rehabilitation in an Indian cardiovascular disease population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundCardiac rehabilitation (CR), an integral component of cardiovascular disease (CVD) management in developed countries, is yet to become mainstream in India. With the prevailing gross mismatch between the need and the (...)
• 01:00
  Prevalence of cardiovascular disease and thromboembolic events in a prospective cohort of patients with sickle cell disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSickle cell disease (SCD) is an inherited disorder of globin chains that cause haemolysis, thrombosis and chronic organ damage. SCD affects multiple organs including the cardiovascular system. The two main subtypes of SCD (...)
• 01:00
  Prevalence of cardiovascular disease in Sickle cell disease (SCD)- An echocardiographic and pharmacological analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSickle cell disease (SCD) is an inherited disorder of globin chains that cause haemolysis and chronic organ damage. It is an autosomal recessive condition. SCD is a condition more prevalent in sub-saharan Africa. It is (...)
• 01:00
  Predictors of outcomes of acute coronary syndrome in women admitted in the coronary care unit, cardiovascular unit and medical ICU of a tertiary hospital from January 2015 to December 2020 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAcute Coronary Syndrome (ACS) is a leading cause of demise in the Asia-Pacific region. Women, especially those more than 65 years old, do not seek treatment immediately because symptoms are usually atypical. A study done in (...)
• 01:00
  Myocardial bridge over coronary arteries and myocardial coat over coronary sinus: a cadaveric study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundMyocardial Bridge (MB) over the coronary artery and myocardial coat (MC) over the cardiac veins are sometimes detected in angiography and cadaveric dissection. Left anterior descending (LAD) branch of left coronary artery (...)
• 01:00
  Secreted APE1/Ref-1 inhibits doxorubicin-induced cardiotoxicity via suppressing ROS generation and p53 pathway Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): This research is supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of (...)
• 01:00
  S-Allylcysteine limits cardiac structural changes via antioxidant status in ovariectomized rats with induced myocardial injury Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Higher Education, Malaysia (Fundamental Research Grant Scheme)BackgroundCardiovascular disease is the primary cause of death in Malaysia. Past studies have shown (...)
• 01:00
  Cardiovascular Profile of patients with COVID-19 infection admitted at a tertiary hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionIn December 2019, a novel Coronavirus disease 2019 (COVID-19) was discovered and spread rapidly worldwide. The virus spared no country in its contagiousness. The most common clinical manifestations are respiratory (...)
• 01:00
  Incidence of myocarditis among patients recovered from COVID-19 infection identified using cardiac magnetic resonance imaging Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCoronavirus disease 2019 (COVID-19) has caused significant morbidity and mortality worldwide and has been associated with several cardiac complications including myocarditis. COVID-19 patients with myocardial injury have (...)
• 01:00
  Association of left atrial ejection fraction and cardiovascular outcomes in Asian patients with hypertrophic cardiomyopathy Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Fellowship SchemeBackgroundThe optimal method of risk stratification of hyp­ertrophic cardiomyopathy (HCM) (...)
• 01:00
  Multicenter registry of the Watchman left atrial appendage closure device for patients with atrial fibrillation in Japan: The TERMINATOR registry Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific JapanBackgroundTranscatheter left atrial appendage closure (LAAC) provides an alternative to oral anticoagulation for thromboembolic risk reduction in patients (...)
• 01:00
  An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOne of the most common co-morbidities identified among COVID-19 patients was hypertension. Debates on use of Angiotensin-Converting Enzyme Inhibitors (ACEI) and Angiotensin-Receptor blockers (ARB) emerged due to an (...)
• 01:00
  Understanding the management of hypertension in Asia: results of a literature search Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Servier, FranceBackgroundHypertension poses a significant healthcare burden in Asia. Detection, treatment and control of hypertension are suboptimal, despite the existence of clear international (...)
• 01:00
  Comparison of risk of hyperkalemia between SGLT2 inhibitors and DPP4-inhibitors in patients with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundHyperkalemia is a common complication and increases the risk of cardiac arrhythmias and mortality in patients with type 2 diabetes (T2DM), especially in those with diabetic nephropathy. We investigated the risk of (...)
• 01:00
  The use of ticagrelor versus clopidogrel in Malaysian patients with coronary artery disease undergoing percutaneous coronary intervention (PCI): Does the age tertile affect the platelet reactivity? Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPrevious studies have shown that the prevalence of cardiovascular diseases is related to the patient's age and gender differences, but the effect of age on platelet function remains controversial. Platelet function should (...)
• 01:00
  Effects of epicardial adipose tissue volume and thickness assessed by computed tomography and echocardiography on cardiovascular and cerebrovascular outcomes: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundEpicardial adipose tissue (EAT) has garnered attention as a potential imaging biomarker for the risk stratification of cardiovascular diseases (CVD). However, the prognostic utility of EAT due to inter-ethnic differences (...)
• 01:00
  Pathophysiologic mechanism for MYOcarditis in COVID-19 VAccinations ("MYOVAx" Study) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): NMRC COVID-19 Research FundObjectiveThis is the first prospective cohort study in Singapore to investigate the COVID-19 vaccine-associated myocarditis to understand its (...)
• 01:00
  Ambient heat exposure after the rainy season is associated with an increased risk of Stroke Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundStroke is a major global health issue and Climate change is the biggest and most urgent challenges. The Asia and Pacific region have been more vulnerable to climate change and extreme heat exposure than other regions of the (...)
• 01:00
  Improving cardiovascular health behaviors through a comprehensive lifestyle intervention program during the pandemic in India Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundWe have witnessed a dramatic dip in adherence to cardiovascular health behaviors during the COVID-19 pandemic. Data from across the globe has shown that risk factors for cardiovascular disease (CVD) such as decreased (...)
• 01:00
  Association between non-alcoholic fatty liver disease and incidence of arrhythmia and other cardiovascular outcomes: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe association between non-alcoholic fatty liver disease (NAFLD) with cardiovascular and cerebrovascular outcomes, as well as their clinical impact, has yet to be established in the literature.ObjectiveWe aim to evaluate (...)
• 01:00
  Incident heart failure and the subsequent risk for progression to end stage kidney disease in South East Asian people with type 2 diabetes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public grant(s) – National budget only. Main funding source(s): Singapore National Medical Research Council grants: CSA-INV/0020/2017 and CS-IRG (MOH-000066)BackgroundHeart failure (HF) is a common but often unrecognized complication of (...)
• 01:00
  Gender distribution in STEMI patients and how does it affect primary PCI performances Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private hospital(s). Main funding source(s): Jakarta Heart CenterBackgroundManaging ST-Segment Elevation Myocardial Infarction (STEMI) patients was always challenging for Healthcare Professionals (HCP) to pursue time-sensitive treatment.1 (...)
• 01:00
  Association between body mass index (BMI) and severity of coronary artery disease in young onset acute coronary syndrome (ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundA high body mass index (BMI) is seems to be associated with an increased incidence of coronary artery disease. If the affected person is young, the consequences are more tragic. There are variable information on the (...)
• 01:00
  Multicenter review of a tadalafil suspension formulation in infants and children with pulmonary hypertension: a north american experience Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundPulmonary arterial hypertension (PAH) is a disease characterised by an increase in pulmonary vascular resistance and pulmonary artery pressure. Phosphodiesterase type 5 (PDE5) inhibitors, with sildenafil the earliest among (...)
• 01:00
  Preliminary findings from a risk stratification, quality of life and burden of illness in pulmonary arterial hypertension pilot study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Janssen Australia and New Zealand (Janssen-Cilag Pty Ltd)Pulmonary Arterial Hypertension (PAH) management strategies focus on lowering mortality risk, extending the patient’s (...)
• 01:00
  Optical Coherence Tomography (OCT) evaluation of culprit lesions in patients with Non-ST Elevation Acute Coronary Syndromes (NSTE-ACS) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundOCT is an excellent tool to determine plaque morphology in Acute Coronary Syndromes. While plaque rupture has been determined to be the dominant morphology in ST Elevation Myocardial Infarction, there is paucity of (...)
• 01:00
  Angiography alone versus angiography plus intracoronary imaging to guide emergency percutaneous coronary intervention: outcomes from a single-centre retrospective analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThere is emerging evidence showing improvement in clinical outcomes with optical coherence tomography (OCT) and intravascular ultrasound (IVUS)-guided elective percutaneous coronary intervention (PCI). Yet data supporting (...)
• 01:00
  Prioritization of invasive coronary angiogram for deserving patients with chronic coronary syndrome (CCS) using an Angiogram Eligibility Scoring (AES) system - A Clinical Audit Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionMany patients with CCS are usually referred for invasive treatment early on first come first serve basis. Proper clinical assessment of the severity of symptoms and optimization of the medical therapy lack before referral (...)
• 01:00
  Modified STEMI protocol for Primary PCI during COVID-19 Pandemic:Does it prolong Door-To-Balloon performance? Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private hospital(s). Main funding source(s): Jakarta Heart CenterBackgroundCOVID-19 became a main health problem and causes heavy impact, especially for healthcare system. Managing ST-Segment Elevation Myocardial Infarction (STEMI) (...)
• 01:00
  Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2 Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): RistekdiktiBackground and AimsThe SARS-CoV-2 virus can infect adipocyte cells via ACE2 Receptor thus triggering ACE2 overexpression and cytokine storms which cause lethal complications. (...)
• 01:00
  Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAtrial fibrillation (AF) and Diabetes mellitus (DM) often coexist. As DM is considered while calculating the thromboembolic risk for AF patients, little is known about the prescription pattern of antithrombotic therapies in (...)
• 01:00
  Effect of therapeutic dose anticoagulation vs prophylactic dose anticoagulation in reducing venous thromboembolism, arterial thrombosis or death events among hospitalized non-critically ill COVID19 pt Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.TitleThe Effect of Therapeutic Dose Anticoagulation Versus Prophylactic Dose Anticoagulation in Reducing Venous Thromboembolism (VTE), Arterial Thrombosis (ATE) or Death Events Among Hospitalized Non-critically Ill COVID-19 Patients: (...)
• 01:00
  Platelet reactivity index after treatment of clopidogrel versus ticagrelor based on CYP2C19 genotypes among patients undergoing percutaneous coronary intervention: results of a randomized study Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough clopidogrel is the basic drug for antiplatelet therapy in patients with coronary artery disease (CAD). However, loss of function (LOF) allelic variants located within the CYP2C19 gene may reduce the production of (...)
• 01:00
  Concurrent left ventricular myocardial diffuse fibrosis and left atrial dysfunction strongly predicts incident heart failure and all-cause mortality Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Foundation. Main funding source(s): British Heart FoundationAcademy of Medical SciencesBackgroundLV myocardial interstitial fibrosis has been reported to influence LA morphology and function via LV remodelling and diastolic dysfunction. (...)
• 01:00
  Comparison of his bundle pacing versus biventricular pacing in heart failure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionDespite optimal medical treatment, the 5-years mortality and HF readmission rate was 75.3% and 48.5%, respectively. The current guidelines recommended cardiac resynchronization therapy (CRT) by implanting biventricular (...)
• 01:00
  Sex difference in neurological outcome and post-cardiac arrest care in out-of-hospital cardiac arrest patients treated with targeted temperature management Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectivesConflicting results regarding sex-based differences in the outcomes of out-of-hospital cardiac arrest (OHCA) patients have been reported. Furthermore, no study has examined whether differences in in-hospital interventions (...)
• 01:00
  Real-world outcomes of Selexipag for treatment of pulmonary hypertension in an Asian population Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSelexipag is an oral selective prostacyclin IP receptor agonist indicated for treatment of pulmonary arterial hypertension (PAH). Data on its real-world safety and efficacy in Asians is lacking.PurposeWe sought to (...)
• 01:00
  A canadian retrospective multicenter experience with selexipag in a heterogeneous group of pediatric pulmonary hypertension patients Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe introduction of the oral prostanoid selexipag for treating severe adult pulmonary arterial hypertension (PH) has contributed to reduced rates of death and secondary complications in PAH. Pediatric physicians have (...)
• 01:00
  Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundThe growing prevalence of metabolic diseases is a major concern. We sought to examine the global trends and mortality of metabolic diseases using estimates from the Global Burden of Diseases, Injuries and Risk Factors Study (...)
• 01:00
  Geographic areas of responsibility among PCI-capable hospitals in the Philippines Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionThe archipelagic nature of the Philippines is unique and the geographic areas of responsibility for ST elevation myocardial infarction patients should be defined.MethodologyThe list of registered PCI capable hospitals and (...)
• 01:00
  Change in minimum indexed left atrial volume predicts incident heart failure: the multi-ethnic study of atherosclerosis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background and PurposeLongitudinal change in the left atrium prior to the onset of heart failure has not been as well studied as left atrial (LA) dysfunction in pre-existing heart failure. This study used cardiac magnetic resonance (...)
• 01:00
  Characteristics and outcomes of patients presenting with out of hospital cardiac arrest to a regional hospital Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionOut of hospital cardiac arrest (OHCA) carries a high rate of mortality and can be due to cardiac or non-cardiac causes. We reviewed consecutive patients presenting with OHCA to the emergency department of a regional (...)
• 01:00
  Vaccination status and knowledge of CPR do not affect medical students' decision to perform BLS during the COVID-19 pandemic Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionTo address the risks of transmission by COVID-19, various recommendations been released by medical societies, which include strongly advocating for the use of personal protective equipment. In addition, hands-only (...)
• 01:00
  Sex-based comparisons of clinical characteristics and outcomes of patients with embolic stroke of undetermined source with implantable loop recorders Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionEmbolic strokes of undetermined source (ESUS) constitute a significant proportion of all ischemic strokes, but sex-based comparisons of clinical characteristics and outcomes of ESUS patients have not been well explored. (...)
• 01:00
  Arterial thromboembolism (ATE) and mortality among COVID-19 patients in the intensive care unit (ICU): prevalence and risk factors Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.ObjectiveTo investigate the prevalence of arterial thromboembolic (TE) complications including stroke, peripheral arterial disease (PAD) and myocardial infarction (MI) and mortality among COVID-19 patients admitted to an ICU at a (...)
• 01:00
  Predictors of left ventricular mass and coronary artery calcium phenotypes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National Medical Research Council, Ministry of Health, Singapore and the Lee FoundationBackgroundLeft ventricular (LV) mass and coronary artery calcium score (CACS) are both independent (...)
• 01:00
  LDL cholesterol an unmet target in diabetic, hypertensive population pan India exposing susceptive cardiovascular disorder risk Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundManagement and pathophysiology of diabetes and hypertension has always been the centre of research, with new insights being found consistently. CVD is the major cause of mortality in patients with type 2 diabetes and (...)
• 01:00
  Demographic, clinical, and echocardiographic factors predicting maintenance of sinus rhythm following first elective cardioversion Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.Background/IntroductionAtrial fibrillation is common. Cardioversion to restore sinus rhythm is successful in over 90% of cases, but reversion to atrial fibrillation within a year occurs in the majority. Although predictors of (...)
• 01:00
  Catheter ablation vs medical therapy for treatment of atrial fibrillation patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionCatheter ablation (CA) is used as a treatment option in selected patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) as studies have shown that it reduces heart failure (HF) (...)
• 01:00
  The efficacy and safety of pulsed-field ablation in para-Hisian paroxysmal supraventricular tachycardia: first-in-human pilot trial Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Public Institution(s). Main funding source(s): National Key Research and Development Program of ChinaBackgroundPara-Hisian paroxysmal supraventricular tachycardia (PSVT) is associated with a higher risk of atrioventricular block due to (...)
• 01:00
  Pregnancy in patients with complete atrioventricular block: management and perinatal outcomes Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.BackgroundAlthough bradyarrhythmias may occur in pregnant patients, there are few data on their management, pregnancy course and perinatal outcomes.PurposeTo evaluate the effects of bradyarrhythmias on the course and outcomes of (...)
• 01:00
  Voltage/mass ratio (VMR) prognosis value in heart failure (HF) patients with transthyretin cardiac amyloidosis (ATTR-CA) Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionTransthyretin cardiac amyloidosis (ATTR-CA) is an emerging cause of heart failure (HF) and is associated with cardiac mass hypertrophy and voltage impairment, but little is known on how theses markers interplay with (...)
• 01:00
  A retrospective study of characteristics and burden of heart failure in Thailand: an interim analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: Private company. Main funding source(s): Novartis (Thailand) LimitedBackground/IntroductionHeart failure (HF) is a major health problem due to its significant prevalence, disease burden and cost, mainly driven by high rates of (...)
• 01:00
  Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis Eur Heart J
  AbstractFunding AcknowledgementsType of funding sources: None.IntroductionSacubitril/Valsartan is the cornerstone in the treatment of heart failure with reduced ejection fraction (HFrEF). However, there is limited data on their risk-benefit in patients with acute heart failure requiring (...)